Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolactin as a factor for increased platelet aggregation.

Ales Urban1, Jirí Masopust, Radovan Malý

  • 1Department of Psychiatry, Charles University in Prague, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Czech Republic. a.urban@centrum.cz

Neuro Endocrinology Letters
|August 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimum mortality temperature by cause of death and age group: A multi-country observational study (1990-2019).

Environmental research·2026
Same author

Temporal changes in mortality risk associated with PM<sub>10</sub> across 143 cities in 26 countries: a multicountry, multicity time-series study.

The Lancet. Planetary health·2026
Same author

The burden of El Niño-Southern Oscillation-related dengue attributable to anthropogenic climate change: a multicountry modelling study.

The Lancet. Planetary health·2026
Same author

The mediating role of acute respiratory infections in temperature-mortality associations in the Czech Republic, 1982-2019.

International journal of biometeorology·2026
Same author

Variation in reporting of heatstroke mortality: evidence from a multi-country study.

The Lancet. Public health·2026
Same author

The joint impact of temperature, humidity, and air pollution on COVID-19 incidence: a multi-country time-series study in 439 cities.

Environment international·2026

Antipsychotic medications may increase the risk of blood clots due to elevated prolactin levels. Prolactin acts as a platelet co-activator, potentially contributing to thrombosis risk.

Area of Science:

  • Pharmacology
  • Endocrinology
  • Hematology

Background:

  • Antipsychotic drug administration is linked to potential risks including venous thromboembolism and cerebrovascular events.
  • The precise biological mechanisms underlying these adverse drug reactions remain under investigation.
  • Elevated prolactin levels are a known side effect of antipsychotic treatment.

Observation:

  • Prolactin has been identified as a significant co-activator of platelet aggregation.
  • This suggests a potential role for hyperprolactinemia in thrombotic events.

Findings:

  • Hyperprolactinemia, induced by antipsychotics, may contribute to platelet activation.
  • This mechanism is hypothesized to increase the risk of both arterial and venous thrombosis.

Related Experiment Videos

Implications:

  • Understanding the role of prolactin in platelet aggregation could inform risk assessment for patients on antipsychotics.
  • Further research into hyperprolactinemia may reveal novel therapeutic targets for preventing thrombosis.
  • This highlights the importance of considering endocrine side effects in psychotropic drug safety.